Under fasting conditions, the dopamine (DA) metabolite homovanillic ac
id (HVA) in plasma originates mainly from central DA neurons or from c
entral and peripheral noradrenergic (NA) neurons. The latter source co
ntributes, in addition to HVA, the norepinephrine metabolites, for exa
mple, 3-methoxy-4-hydroxyphenylglycol (MHPG). It has been shown in pri
mates that the association between HVA and MHPG in plasma or urine und
er varying rates elf NA metabolism can be used to obtain an estimate o
f the central DA neuronal contribution of HVA to plasma or urine. This
estimate is called the central dopaminergic index (CDI). Two studies
presented here examine the applicability of this model in schizophreni
a patients. The results were consistent with the proposed model and su
ggested that only about 30 percent of the total plasma HVA concentrati
ons in our patients were derived from central DA neurons. A convenient
modification of this model is proposed for future studies. Since the
CDI of plasma HVA is not likely to be confounded by NA activity, this
tool may prove useful in disentangling the roles played by the DA and
NA systems in schizophrenia.